DGMT service contract on PacBio Revio sequencer

The Food and Drug Administration has forecasted a service contract for maintenance and support of a PacBio Revio next-generation sequencing instrument under the NAICS code 811219, which pertains to other commercial and industrial machinery and equipment repair and maintenance. This contract is intended to ensure the continuous operational integrity and performance of the high-throughput sequencing platform used for critical scientific and regulatory applications. The point of contact for program-related inquiries is the Nctr Acquisition Liaison, reachable via nctracquisitions@fda.hhs.gov, while the contracting officer role remains undetermined at this time. The contract opportunity was posted on May 25, 2026, and is listed as a forecast, indicating it is not yet available for bidding but serves as advance notice for potential vendors. No specific set-aside designation, place of performance, or solicitation number has been provided. The agency has not yet finalized details regarding the location or contracting officer, but interested parties should monitor the official Osdbu HHS portal for updates and eventual launch of a formal solicitation. No financial parameters or contract duration are disclosed at this stage, and all details remain subject to change pending full procurement planning.